NeoGenomics, Inc. Stock OTC Bulletin Board
Equities
US64049M2098
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
|
May. 28 | NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO | CI |
May. 02 | North American Morning Briefing : Stock Futures -3- | DJ |
Financials (USD)
Sales 2024 * | 656M | Sales 2025 * | 719M | Capitalization | 2.02B |
---|---|---|---|---|---|
Net income 2024 * | -72M | Net income 2025 * | -47M | EV / Sales 2024 * | 3.49 x |
Net Debt 2024 * | 265M | Net Debt 2025 * | 238M | EV / Sales 2025 * | 3.14 x |
P/E ratio 2024 * |
-27.8
x | P/E ratio 2025 * |
-43.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.75% |
Latest transcript on NeoGenomics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
Lynn Tetrault
CHM | Chairman | 61 | 15-06-11 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 22-12-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kelly
BRD | Director/Board Member | 67 | 20-07-14 |
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
David Perez
BRD | Director/Board Member | 63 | 22-11-02 |
1st Jan change | Capi. | |
---|---|---|
-16.93% | 8.48B | |
+87.40% | 4.81B | |
+16.31% | 2.99B | |
-3.15% | 2.65B | |
-53.27% | 1.87B | |
-12.97% | 1.58B | |
+21.59% | 1.25B | |
-47.96% | 1.06B | |
-4.64% | 1B |